DnB Asset Management
AMED

DnB Asset Management’s Amedisys AMED Stock Holding History

DnB Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,104
Closed -$1.89M – 631
2018
Q3 		$1.89M Sell
15,104
-54,900
-78% -$6.06M 0.02% 419
2018
Q2 		$5.98M Sell
70,004
-600
-0.8% -$44.1K 0.07% 192
2018
Q1 		$4.26M Hold
70,604
– – 0.05% 242
2017
Q4 		$3.72M Buy
+70,604
New +$3.72M 0.04% 254

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DnB Asset Management's AMED Position: Q4 2018 in Review

DnB Asset Management sold out of Amedisys (AMED) in Q4 2018, closing a stake of 15,104 shares — an estimated $1.89M sold.

DnB Asset Management first reported a position in AMED in Q4 2017 and held it in 4 quarters. The position peaked at $5.98M in Q2 2018. 297 funds tracked by Wall St. Rank hold AMED as of Q4 2018.

  • DnB Asset Management reported no remaining Amedisys position as of Q4 2018 after selling out during the quarter.
  • DnB Asset Management sold 15,104 Amedisys shares in Q4 2018, an estimated $1.89M.
  • DnB Asset Management first reported a position in Amedisys in Q4 2017 and held it in 4 quarters.
  • DnB Asset Management's Amedisys position peaked at $5.98M in Q2 2018.
  • 297 funds tracked by Wall St. Rank held Amedisys as of Q4 2018.

Based on DnB Asset Management's 13F filing for Q4 2018, filed 15 Jan 2019.